Show simple item record

dc.contributor.authorLunde, Kristin Aaser
dc.contributor.authorChung, Janete
dc.contributor.authorDalen, Ingvild
dc.contributor.authorPedersen, Kenn Freddy
dc.contributor.authorLinder, Jan
dc.contributor.authorDomellöf, Magdalena E.
dc.contributor.authorElgh, Eva
dc.contributor.authorMacLeod, Angus
dc.contributor.authorTzoulis, Charalampos
dc.contributor.authorLarsen, Jan Petter
dc.contributor.authorTysnes, Ole-Bjørn
dc.contributor.authorForsgren, Lars
dc.contributor.authorCounsell, Carl E.
dc.contributor.authorAlves, Guido
dc.contributor.authorMaple-Grødem, Jodi
dc.date.accessioned2019-05-20T23:05:24Z
dc.date.available2019-05-20T23:05:24Z
dc.date.issued2018-10
dc.identifier.citationLunde , K A , Chung , J , Dalen , I , Pedersen , K F , Linder , J , Domellöf , M E , Elgh , E , MacLeod , A , Tzoulis , C , Larsen , J P , Tysnes , O-B , Forsgren , L , Counsell , C E , Alves , G & Maple-Grødem , J 2018 , ' Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease ' , Alzheimer's and Dementia , vol. 14 , no. 10 , pp. 1293-1301 . https://doi.org/10.1016/j.jalz.2018.04.006en
dc.identifier.issn1552-5260
dc.identifier.otherPURE: 118755970
dc.identifier.otherPURE UUID: 991b365f-6f98-4beb-9d04-8bbc99543499
dc.identifier.otherScopus: 85049877845
dc.identifier.otherWOS: 000446086000006
dc.identifier.urihttp://hdl.handle.net/2164/12286
dc.descriptionPINE was supported by Parkinson’s UK (grant numbers G0502, G0914, G1302), Scottish Government Chief Scientist Office, BMA Doris Hillier Award, the BUPA Foundation, NHS Grampian Endowments, and RS MacDonald Trust. The Norwegian ParkWest study has been funded by the Research Council of Norway (grant number 177966), the Western Norway Regional Health Authority (grant number 911218), Stavanger University Hospital Research Funds (grant number 501611), and the Norwegian Parkinson’s Disease Association. Janete Chung and Kristin Aaser Lunde are supported by the Western Norway Regional Health Authority (grant numbers 911859 and 911830). The NYPUM study has been funded by the Swedish Medical Research Council, the Swedish Parkinson’s Disease Association, the Swedish Parkinson Foundation, Erling Persson Foundation, Kempe Foundation and the Västerbotten County Council. The funding sources had no role in the design and conduct of the study: collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript: and decision to submit the manuscript for publication.en
dc.format.extent9en
dc.language.isoeng
dc.relation.ispartofAlzheimer's and Dementiaen
dc.rights© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectParkinson's diseaseen
dc.subjectParkinson's disease with dementiaen
dc.subjectGBAen
dc.subjectLongitudinalen
dc.subjectgenetic associationen
dc.subjectR Medicine (General)en
dc.subjectParkinson's UKen
dc.subjectG0502en
dc.subjectG0914en
dc.subjectG1302en
dc.subjectChief Scientist Office (CSO)en
dc.subject.lccR1en
dc.titleAssociation of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's diseaseen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen, Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.jalz.2018.04.006
dc.date.embargoedUntil21-05-20


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record